|
Market Closed -
Euronext Paris
01:55:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 74.86 EUR | +0.43% |
|
-3.23% | +19.97% |
| 02/10 | Eurofins Completes Sale of MET Labs Business | MT |
| 02/10 | UL Solutions Completes Acquisition of Eurofins' Electrical, Electronics Business | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.63B | |||||
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
- Stock Market
- Stocks
- ERF Stock
- Charts Eurofins Scientific SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
